Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 4/20 | 0.49 |
| ▸ | SCTR | P47872 | 1/20 | 0.49 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.47 |
| ▸ | TFPI | P10646 | 1/20 | 0.47 |
| ▸ | MC4R | P32245 | 1/20 | 0.47 |
| ▸ | CALCR | P30988 | 4/20 | 0.47 |
| ▸ | BACE1 | P56817 | 6/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.47 |
| ▸ | GRPR | P30550 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30209777 | 0.93 | GLP1R (0.50) | GLP1RSCTRC5AR1TFPICALCR | |
| SCHEMBL30209778 | 0.91 | BACE1 (0.56) | GLP1RSCTRTFPICALCRBACE1 | |
| SCHEMBL29748370 | 0.90 | MC4R (0.45) | GLP1RSCTRC5AR1MC4RF2 | |
| SCHEMBL31438606 | 0.88 | TFPI (0.54) | GLP1RSCTRTFPICALCRGRPR | |
| SCHEMBL31442273 | 0.88 | GLP1R (0.51) | GLP1RSCTRF2 | |
| SCHEMBL31442112 | 0.88 | GLP1R (0.50) | GLP1RSCTRCALCRF2 | |
| SCHEMBL29394888 | 0.87 | GLP1R (0.58) | GLP1RSCTRCALCR | |
| SCHEMBL29802142 | 0.87 | OPRD1 (0.47) | GLP1RSCTR | |
| SCHEMBL29922493 | 0.87 | GLP1R (0.57) | GLP1RSCTRCALCRF2 | |
| SCHEMBL30425532 | 0.86 | MC4R (0.45) | GLP1RSCTRMC4RCALCRF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116490215-A | Targeted mediated endocytic drug delivery | CRM医疗有限公司 | 2023-07-25 | — | — | CN | disclosed |